Beth Devine - Concepedia

Author

Beth Devine

Also Known As

(Emily) Beth Devine, B DEVINE, B Devine, B. Devine, Beth Devine, Brynn Devine, Desola Davis, Devine, Beth, Devine, Emily Beth, Sonia Deutsch

208

Publications

Citations

H-Index

104

Concepts

All Affiliations

University of Washington University of Washington Medical Center Allergan (United States)Oregon Health & Science University University of British Columbia

About

Beth Devine is an author at University of Washington specializing in medicine, public health, and health services research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.9K
2	Health Sciences	7	7	555
3	Nursing	3	3	1.1K
4	Business	1	1	10
5	Management	1	1	83

Beth Devine

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1 Jeroen P. Jansen, Rachael Fleurence, Beth Devine, Value in Health NursingFamily MedicineCounselingNetwork Meta-analysisPart 1	2011	1K
Primary Care–Based Models for the Treatment of Opioid Use Disorder P. Todd Korthuis, Dennis McCarty, Melissa B. Weimer, Annals of Internal Medicine Opioid EpidemicFamily MedicineCare ModelsSubstance UseDrug Treatment	2016	287
Outcomes From Health Information Exchange: Systematic Review and Future Research Needs William Hersh, Annette M Totten, Karen Eden, JMIR Medical Informatics	2015	132
Returning integrated genomic risk and clinical recommendations: The eMERGE study Jodell E. Linder, Aimee Allworth, Harris T. Bland, Genetics in Medicine Emerge StudyGenome-wide Association StudyPolygenic RiskGenetic EpidemiologyGenomics	2023	104
Inclusion of Patient-Reported Outcome Measures In Registered Clinical Trials: Evidence From Clinicaltrials.Gov (2007-2013) Elisabeth Vodicka, K. Kim, Beth Devine, Value in Health Clinical EffectivenessClinical Trial ManagementClinical EndpointClinical TrialsOutcomes Research	2015	101
Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance KATE JOHNSON, Boshen Jiao, Scott D. Ramsey, Blood Advances Health Insurance DesignPopulation Health SciencesHealth DisparitiesFinancial ProtectionHealth Care Finance	2022	83
Collaborative Drug Therapy Management by Pharmacists Jannet M. Carmichael, Mary Beth O’Connell, Beth Devine, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy Pharmaceutical PracticePharmacologyClinical PharmacyPharmaceutical CarePharmacotherapy	1997	77
Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries Boshen Jiao, KATE JOHNSON, Scott D. Ramsey, Blood Advances Health Insurance DesignPopulation Health SciencesLong-term SurvivalHealth DisparitiesEpidemiology Of Aging	2023	56
Medication-Assisted Treatment Models of Care for Opioid Use Disorder in Primary Care Settings Roger Chou, P. Todd Korthuis, Melissa B. Weimer, Europe PMC (PubMed Central) Opioid EpidemicFamily MedicineSubstance UseDrug TreatmentMedication-assisted Treatment Models	2016	50
Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine Patrick Gillard, Beth Devine, Sepideh F. Varon, Value in Health Disease-specific MeasuresQuality Of LifeCluster HeadacheHealth SciencesPsychiatry	2012	45

Page 1